Teva Pharmaceutical Industries Ltd. has agreed to acquire Representaciones e Investigaciones Médicas, S.A. de C.V. (Rimsa), a pharmaceutical manufacturing and distribution company in Mexico, along with a portfolio of products and companies, intellectual property, assets and pharmaceutical patents in Latin America and Europe for $2.3 billion.

Rimsa had revenue in 2014 of $227 million with an annual growth, year over year of 10.6% since 2011. The company has a portfolio of specialty products, including fixed-dose combination products.

Teva expects to close these transactions by early first quarter, 2016.

Source: Teva Pharmaceutical Industries